A qualitative study to identify factors influencing COXIB prescribed by family physicians for musculoskeletal disorders

Family Practice

Volumn 23, Issue 6, 2006, Pages 659-665

  Klein, Douglas ^a   MacDonald, A ^a   Drummon, N ^a   Cave, A ^a  

^a 2 590 Edmonton Clinic Health Academy   (Canada)

Author keywords

Cyclo oxygenase 2 inhibiting anti inflammatories; Musculoskeletal disorders; Prescribing

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CANADA; CLINICAL PRACTICE; DECISION MAKING; FEMALE; FIBROMYALGIA; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; INJURY; INTERVIEW; MALE; METHODOLOGY; MUSCULOSKELETAL DISEASE; OSTEOARTHRITIS; QUALITATIVE RESEARCH; RHEUMATOID ARTHRITIS; STANDARD; STATISTICS;

ALBERTA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; CYCLOOXYGENASE 2 INHIBITORS; DECISION MAKING; FAMILY PRACTICE; FEMALE; FIBROMYALGIA; HUMANS; INTERVIEWS; MALE; MUSCULOSKELETAL DISEASES; OSTEOARTHRITIS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; QUALITATIVE RESEARCH; RESEARCH DESIGN; SPRAINS AND STRAINS;

EID: 36049044150     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cml048     Document Type: Article

References (27)

1. Tannenbaum H, Peloso PMJ, Russell AS, Marlow B. An evidence-based approach to prescribing NSAIDS in the treatment of osteoarthritis and rheumatoid arthritis: The Second Canadian Consensus Conference. Can J Clin Pharmacol 2001; 7 (Supplement A): 4A-16A.
2. Sun J, Gooch K, Novak K, Svenson LW, Frank C. Prevalence of NSAID use among Alberta seniors in 2002-2003. Ann Epidemiol 2004; 14(8): 603.
3. Zelnio R. The interaction among the criteria physicians use when prescribing. Med Care. 1982; 20(3): 277-285.
4. Epstein A, Leighton J, Winickoff R. Physicians beliefs, attitudes, and prescribing behavior for anti-inflammatory drugs. Am. J. Med 1984; 77: 313-318.
5. Davidson W, Molloy W, Somers G, Bedard M. Relation between physician characteristics and prescribing for elderly people in New Brunswick. Can Med Assoc J 1994; 150(6): 917-921.
6. Hart J, Salman H, Bergman M, Neuman V, Rudniki C, Gilenberg D et al. Do drug costs affect physicians' prescription decisions? J Int Med 1997; 214: 415-420.
7. Denig P, Wahlstrom R, Chaput de Saintonge M, Haaijer-Ruskamp F. The value of clinical judgement analysis for A qualitative study to identify factors influencing COXIB 665 improving the quality of doctors' prescribing decisions. Med Educ 2002; 36: 770-780.
8. Denig P, Haaijer-Ruskamp FM, Zusling DH. How physicians choose drugs. Soc Sci Med 1988; 27(12): 1381-1386.
9. Jenicek M. Foundations of Evidence-based Medicine. London: The Parthenon Publishing Group, 2003.
10. Holt W, Mazzuca S. Prescribing behaviors of family physicians in the treatment of osteoarthritis. Fam Med 1992; 24: 524-527.
11. Clinard F, Sgro C, Bardou M, Dumas M, Hillon P, Bonithon-Kopp C. Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-based survey in France. Pharmacoepidemiol Drug Saf 2001; 10: 329-338.
12. Cutts C, LaCaze A, Tett S. A clinical audit of the prescribing of celecoxib and rofecoxib in Australian rural general practice. Br J Clin Pharmacol 2002; 54(5): 522-527.
13. Schwartz RK, Soumerai SB, Avorn J. Physician motivations for non-scientific drug prescribing. Soc Sci Med 1989; 28: 577-582.
14. Webb S, Lloyd M. Prescribing and referral in general practice: a study of patients' expectations and doctors' actions. Br J Gen Pract 1994; 44: 165-169.
15. Britten N, Ukoumunne OC, Boulton MG. Patients' attitudes to medicines and expectations for prescriptions. Health Expect 2002; 5: 256-269.
16. Ritchie J, Spencer L. Quantitative data analysis for applied policy research. In: Bryman A, Burgess R, (eds). Analysing qualitative data. London: Routledge. 1994.
17. Schumock GT, Walton SM, Park HY, Nutescu EA, Blackburn JC, Finley JM et al. Factors that influence prescribing decisions. Ann Pharmacother 2004; 38(4): 557-562.
18. Strang D, Gagnon M, Molloy W, Bedard M, Darzins P, Etchells E et al. National survey on the attitudes of Canadian physicians towards drug-detailing by pharmaceutical representatives. Ann R Coll Physicians Surg Can 1996; 29(8): 47-48.
19. Caudill TS, Johnson MS, Rich EC, McKinney WP. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med 1996; 5(4): 201-206.
20. Morelli D, Koenigsberg MR. Sample medication dispensing in a residency practice. J Fam Pract 1992; 34: 42.
21. Denig P, Witteman CLM, Schouten HW. Scope and nature of prescribing decisions made by general practitioners. Qual Saf Health Care 2002; 11(2): 137-143.
22. Gilbody S, Wilson P, Watt I. Benefits and harms of direct to consumer advertising: a systematic review. Qual Saf Health Care 2005; 14(4): 246-250.
23. Spence MM, Teleki SS, Cheetham TC, Schweitzer SO, Millares M. Direct-to-consumer advertising of COX-2 inhibitors: effect on appropriateness of prescribing. Med Care Res Rev 2005; 62(5): 544-559.
24. Brittan N, Ukoumunne O. The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: a questionnaire survey. BMJ 1997; 315: 1506-1510.
25. Gilhooley M. Heal the damage: prescription drug consumer advertisements and relative choices. J Health Law 2005; 38(1): 1-44.
26. Carthy P, Harvey I, Brawn R, Watkins C. A study of factors associated with cost and variation in prescribing among GPs. Fam Pract 2000; 17(1): 36-41.
27. Kasje WN, Timmer JW, Boendermaker PM, Haaijer-Ruskamp FM. Dutch GPs' perceptions: the influence of out-of-pocket costs on prescribing. Soc Sci Med 2002; 55(9): 1571-1578.